Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Khosla Ventures Acquisition Co.
Drug discovery startup Valo goes public via SPAC merger with Khosla Ventures
By
Mallory Hackett
|
01:38 pm |
June 09, 2021
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.